(Q35165399)

6 August 2017

1 reference

title

Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens (English)

1 reference

Bordetella bronchiseptica

6 August 2017

1 reference

object named as

Bordetella bronchiseptica

1 reference

Andrew Stevenson

1

1 reference

6 August 2017

Mark Roberts

series ordinal

2

1 reference

6 August 2017

publication date

1 July 2003

1 reference

FEMS Immunology and Medical Microbiology

6 August 2017

published in

1 reference

6 August 2017

volume

37

1 reference

6 August 2017

issue

2-3

1 reference

6 August 2017

page(s)

121-128

1 reference

The mucosal immune system: from fundamental concepts to vaccine development

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Immunomodulators and delivery systems for vaccination by mucosal routes.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Recent advances in mucosal vaccines and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Nasal vaccination using live bacterial vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Human infections associated with Bordetella bronchiseptica

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Genetic analysis of the Bordetella infectious cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Immunity to Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Prophylaxis of Bordetella bronchiseptica infection in guinea pigs by intranasal vaccination with live strain ts-S34

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Construction and vaccine potential of an aroA mutant of Pasteurella haemolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin fromBordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Compartmentalization within the common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Cattle immune responses to tetanus toxoid elicited by recombinant S. typhimurium vaccines or tetanus toxoid in alum or Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900068-3

7 January 2021

10.1016/S0928-8244(03)00068-3

Identifiers

DOI

1 reference

release_2y3xmmxmarg3fcqco7g6brmhcm

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2y3xmmxmarg3fcqco7g6brmhcm

24 November 2022

mapped directly with Wikidata item

1 reference